CPHARM - CRC Study

Starting soon · Not applicable

Conditions studied: Colorectal Cancer

In brief

Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.

Key facts

Study ID

NCT07714291

Run by

Monash University Malaysia

People needed

316

Starts

2026-11-01

Expected to finish

2027-01-01

Last updated by the study team

2026-07-21

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 50 to 75 years
• Visiting participating community pharmacies during the study period
• Able to provide informed consent
• Willing to complete the study questionnaire
• Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results

You may not qualify if…

• Previous diagnosis of colorectal cancer
• History of colonoscopy within the recommended screening interval (within past 1 year)
• Currently experiencing symptoms suggestive of colorectal cancer
• Having a first-degree relative diagnosed with colorectal cancer

Where it is running

• Big Caring Group — Klang, Selangor, Malaysia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.